Drug profile · INN
propoxyphene hydrochloride
PROPOXYPHENE HYDROCHLORIDE
propoxyphene hydrochloride (PROPOXYPHENE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — propoxyphene hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
propoxyphene hydrochloride (PROPOXYPHENE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is propoxyphene hydrochloride?
propoxyphene hydrochloride (PROPOXYPHENE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for propoxyphene hydrochloride?
PROPOXYPHENE HYDROCHLORIDE is a marketed brand name for propoxyphene hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propoxyphene hydrochloride?
propoxyphene hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.